Stryker Corporation (SYK)

Market Cap	147.03B
Revenue (ttm)	21.97B
Net Income (ttm)	3.59B
Shares Out	381.22M
EPS (ttm)	9.33
PE Ratio	41.35
Forward PE	29.31
Dividend	$3.20 (0.83%)
Ex-Dividend Date	Sep 30, 2024

Volume	781,996
Open	389.85
Previous Close	388.68
Day's Range	382.25 - 389.98
52-Week Range	285.79 - 398.20
Beta	0.92
Analysts	Buy
Price Target	395.42 (+2.53%)
Earnings Date	Oct 29, 2024

About SYK

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1941
• Employees: 26,700
• Stock Exchange: NYSE
• Ticker Symbol: SYK
• Website: https://www.stryker.com

Financial Performance

In 2023, Stryker's revenue was $20.50 billion, an increase of 11.11% compared to the previous year's $18.45 billion. Earnings were $3.17 billion, an increase of 34.22%.

Analyst Forecast

According to 19 analysts, the average rating for SYK stock is "Buy." The 12-month stock price forecast is $395.42, which is an increase of 2.53% from the latest price.

Price Target

$395.42

(2.53% upside)

Analyst Consensus: Buy